Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TRB Chemedica International, Eaux-Vives.
For over 40 years, TRB Chemedica International have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology. TRB Chemedica is a Swiss pharmaceutical company, focus on research & development in specific therapeutic areas, including rheumatology, ophthalmology and neurology.
05/06/2025
Join TRB Chemedica at the EuDEC 2025 in Krakow, June 19-21! Visit us at Booth 9 to explore our trusted solutions and commitment to improving patient care. We're also proud to welcome you on June 21 at 11:30am to our satellite symposium discussing a new European expert consensus on pediatric dry eye.
We’re proud to announce that an e-poster featuring TRB Chemedica’s Ostenil® Plus will be presented at the ISAKOS Congress 2025! The study compares the efficacy of our 2% sodium hyaluronate solution to corticosteroids in isolated patellofemoral osteoarthritis.
Presented by leading experts from Thailand, this research highlights the benefits of Ostenil® Plus in improving patient outcomes.
Visit us at Booth 21 to explore this study and our commitment to advancing musculoskeletal health.
Join us on June 30th from 6 PM to 7 PM (CET) for a TRB Academy webinar featuring Prof. Hirschmüller, renowned expert in sports medicine, orthopedics and traumatology.
📌Topic: Tailoring Injectable Treatments for Tendinopathies:
From Evidence to Clinical Practice
Discover the latest scientific insights and practical approaches for treating tendinopathies with injectable therapies.
Be part of the conversation that connects cutting-edge research with hands-on clinical practice.
24/04/2025
Join TRB Chemedica at the Isokinetic Conference in Madrid from May 3-5. Discover our commitment to enhancing musculoskeletal health and improving patient outcomes. As a Swiss-based company, we pride ourselves on our dedication to quality and patient care. Visit us at Booth 29-31 to explore our solutions and engage with our and don't miss the chance to lift a replica of the Champions League cup on our booth! 🏆 😉
Find out more https://bit.ly/4cO7eRQ
04/04/2025
Join us at the 25th WCO-IOF-ESCEO Congress in Rome! From April 10-13, 2025, visit us at Stand n°2 to learn how TRB Chemedica is advancing care for patients with musculoskeletal diseases. Osteoporosis and osteoarthritis are key focuses for us, and we’re eager to connect with you on this topic. Discover more about our expertise at https://bit.ly/44b2qU9
06/02/2025
Join TRB as our newest Regulatory Affairs Specialist.
Visit https://buff.ly/3CB5zRZ to apply.
We look forward to receiving your application!
For over 25 years, TRB has remained committed to supporting individuals affected by arthritis and joint discomfort. World Arthritis Day reminds us of the ongoing importance of providing care and solutions that improve the lives of those dealing with joint pain and reduced mobility.
Find out how can aid in improving joint mobility and easing the impact of osteoarthritis
➡️ https://bit.ly/4gA3m8o
Together, let’s work towards healthier joints and a better quality of life.
18/09/2024
📢TRB will attend the Convention on Pharmaceutical Ingredients in Milano. Visit us at booth 14F54 (Hall 14) from October 8 to 10. We look forward to connecting with you.
📢We're attending the 7th ICRS Summit in Catania, Italy, to discuss cartilage regeneration and joint preservation; meet us at our TRB Congress Booth 19 from September 25-27, 2024, for product presentations.
👉 Learn more https://bit.ly/3Z9HOJH
Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TRB Chemedica International erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.
We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.
Founded by Dr Guido Di Napoli in 1980, TRB Chemedica followed a gradual business evolution and expansion through the development of a worldwide network of subsidiaries and distributors.
For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology.
Our medium-sized company, supported by an exclusive network of affiliates, agents and partners, makes us efficient and responsive in the market, with the ability to develop customized solutions for patients and partners in our three focus areas that are hyluronic acid diacerein and GM1 ganglioside.
As a family firm from our foundation, we have strong values that are shared by everyone from the boardroom to the factory.